The store will not work correctly when cookies are disabled.
N'-(5-bromo-2-hydroxybenzylidene)-2,5-dimethylfuran-3-carbohydrazide
ID: ALA4869541
PubChem CID: 135411341
Max Phase: Preclinical
Molecular Formula: C14H13BrN2O3
Molecular Weight: 337.17
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C(=O)N/N=C/c2cc(Br)ccc2O)c(C)o1
Standard InChI: InChI=1S/C14H13BrN2O3/c1-8-5-12(9(2)20-8)14(19)17-16-7-10-6-11(15)3-4-13(10)18/h3-7,18H,1-2H3,(H,17,19)/b16-7+
Standard InChI Key: DERCDAOBUZPTJL-FRKPEAEDSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
32.3166 -27.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0304 -27.0054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7456 -27.4168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4594 -27.0032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1733 -27.4159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3178 -28.2441 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.1697 -28.2398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8827 -28.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5980 -28.2406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5959 -27.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8823 -27.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3093 -26.9972 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
34.4540 -28.6504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5999 -27.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5123 -26.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7050 -26.0213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2935 -26.7365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8467 -27.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6765 -28.1559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3683 -25.2681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
1 6 2 0
5 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 5 1 0
10 12 1 0
7 13 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 14 2 0
1 14 1 0
18 19 1 0
16 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 337.17 | Molecular Weight (Monoisotopic): 336.0110 | AlogP: 3.13 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.83 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.33 | CX Basic pKa: 0.25 | CX LogP: 2.97 | CX LogD: 2.92 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -1.61 |
References
1. (2020) Inhibitors of GPR174 and Uses Thereof, |
2. (2020) Methods and Compositions for Treating Cancer, |